Could one insulin shot a day be enough for gestational diabetes?

NCT ID NCT07171684

Recruiting now Disease control Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a single daily dose of long-acting insulin can control blood sugar as well as the usual regimen of long-acting insulin plus mealtime insulin in pregnant women with diabetes. About 176 participants will be randomly assigned to one of the two approaches and will share their blood sugar logs weekly for dose adjustments. The goal is to simplify treatment while ensuring safety for both mother and baby.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES IN PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus gestational diabetes type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES IN PREGNANCY GESTATIONAL DIABETES

Contacts and locations

Locations

Maternal-Fetal Medicine at NYU Langone Obstetrics & Gynecology Associates
NOT_YET_RECRUITING

New York, New York, 10022, United States
Robert Wood Johnson Univeristy Hospital
RECRUITING

New Brunswick, New Jersey, 08901, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.